1. Home
  2. PINE vs BDSX Comparison

PINE vs BDSX Comparison

Compare PINE & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpine Income Property Trust Inc.

PINE

Alpine Income Property Trust Inc.

N/A

Current Price

$16.64

Market Cap

317.1M

Sector

Real Estate

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$8.58

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PINE
BDSX
Founded
2019
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.1M
276.2M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PINE
BDSX
Price
$16.64
$8.58
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$19.90
★ $39.00
AVG Volume (30 Days)
★ 184.4K
69.7K
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 7.68%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.42
N/A
Revenue
$60,532,000.00
★ $88,499,000.00
Revenue This Year
$31.91
$26.35
Revenue Next Year
$10.40
$20.40
P/E Ratio
$40.21
★ N/A
Revenue Growth
15.90
★ 24.08
52 Week Low
$15.29
$5.26
52 Week High
$21.99
$31.97

Technical Indicators

Market Signals
Indicator
PINE
BDSX
Relative Strength Index (RSI) 42.58 18.42
Support Level $16.62 N/A
Resistance Level $19.93 $11.57
Average True Range (ATR) 0.63 2.10
MACD 0.03 -0.93
Stochastic Oscillator 37.48 6.32

Price Performance

Historical Comparison
PINE
BDSX

About PINE Alpine Income Property Trust Inc.

Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: